← Open Payments lookup

MONICA DUBE: Open Payments

NPI 1417058801 · BURLINGTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,056 in 9 payments from 8 companies in 2025. Trend: 2023 $698 · 2024 $937 · 2025 $1,056

Food & beverage: $1,056
CompanyPaymentsAmount
Otsuka Pharmaceutical Development & Commercialization, Inc.2$198
Alnylam Pharmaceuticals Inc.1$146
Madrigal Pharmaceuticals1$140
HEARTFLOW, INC.1$133
AstraZeneca Pharmaceuticals LP1$122
GlaxoSmithKline, LLC.1$109
ABBVIE INC.1$107
ACADIA Pharmaceuticals Inc1$101

Products named: REXULTI, AMVUTTRA, REZDIFFRA, FFRct, AIRSUPRA, BLUJEPA, SKYRIZI, NUPLAZID.

Industry payments across MA — which companies pay providers there.